Wednesday, December 09, 2015 5:05:54 PM
Who really knows, they waited til the end of the day to PR the news, even though it was posted here this morning. Depends on how many people figured it out before the news this afternoon. I would expect a run to at least $1 tomorrow morning and from there we will have to see where it settles. I would assume they will PR about the presentation tomorrow morning which should help as well.
As far as ODD being baked in I personally don't think it matters. It's one piece to the puzzle here. If you are trading it based on whether or not they would get ODD then by all means sell and be on your way, but you would be making a huge mistake in IMO (I know you are in this for the longer haul per your statements from yesterday, just wanted to mention this point for anyone else).
The culmination of these events, I believe, will propel us much higher and would assume we break and hold above $1 before years end. I would really love to see that $1 mark become support for us into the beginning of next year which I think is highly plausible. After that who knows where we will end up price wise but I will definitely be around to enjoy it.
My only advice to anyone is that if you are holding for the long term don't get tied up in single event. Whats going to move us forward is all of the pieces coming together.
As far as ODD being baked in I personally don't think it matters. It's one piece to the puzzle here. If you are trading it based on whether or not they would get ODD then by all means sell and be on your way, but you would be making a huge mistake in IMO (I know you are in this for the longer haul per your statements from yesterday, just wanted to mention this point for anyone else).
The culmination of these events, I believe, will propel us much higher and would assume we break and hold above $1 before years end. I would really love to see that $1 mark become support for us into the beginning of next year which I think is highly plausible. After that who knows where we will end up price wise but I will definitely be around to enjoy it.
My only advice to anyone is that if you are holding for the long term don't get tied up in single event. Whats going to move us forward is all of the pieces coming together.
Friends don't let friends place market orders
Recent MRKR News
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 05/15/2026 09:00:38 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/04/2026 08:30:23 PM
- Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material • Edgar (US Regulatory) • 03/20/2026 08:08:49 PM
- Form ARS - Annual Report to Security Holders • Edgar (US Regulatory) • 03/20/2026 08:07:05 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 03/20/2026 08:05:49 PM
- Marker Therapeutics Reports Year-End 2025 Corporate and Financial Results • GlobeNewswire Inc. • 03/18/2026 09:31:30 PM
- Marker Therapeutics to Present at the Oppenheimer 36th Annual Healthcare Life Sciences Conference • GlobeNewswire Inc. • 02/18/2026 01:00:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/09/2026 09:06:45 PM
- Good Morning America Features Baylor College of Medicine Pancreatic Cancer Study Utilizing Marker Therapeutics’ MAR-T Cell Technology • GlobeNewswire Inc. • 01/26/2026 12:00:00 PM
- Baylor College of Medicine Publishes Promising Safety and Efficacy Results of Multi-Antigen Targeted T Cells in Patients with Pancreatic Cancer • GlobeNewswire Inc. • 01/05/2026 12:00:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 11/19/2025 09:10:21 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 11/19/2025 09:01:15 PM
- Form SCHEDULE 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend] • Edgar (US Regulatory) • 11/17/2025 09:22:54 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/14/2025 12:20:47 PM
- Marker Therapeutics Reports Third Quarter 2025 Financial Results and Provides Business Updates • GlobeNewswire Inc. • 11/14/2025 12:00:00 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/13/2025 10:29:46 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/05/2025 12:36:59 PM
- Marker Therapeutics appoints Kathryn Penkus Corzo to Board of Directors • GlobeNewswire Inc. • 11/05/2025 12:30:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 11/04/2025 10:09:13 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 11/04/2025 10:03:27 PM
- Form 3 - Initial statement of beneficial ownership of securities • Edgar (US Regulatory) • 11/04/2025 09:54:39 PM
- Marker Therapeutics Announces Upcoming Presentations on MT-601 in Relapsed Non-Hodgkin and Hodgkin Lymphoma at the 67th ASH Annual Meeting • GlobeNewswire Inc. • 11/03/2025 02:15:00 PM
- Marker Therapeutics Announces First Patient Treated in Off-the-Shelf Program • GlobeNewswire Inc. • 10/06/2025 11:30:59 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/06/2025 11:30:37 AM
